Federal Register Notice: FDA’s Endocrinologic and Metabolic Drugs Advisory Committee will meet 9/8 at the Holiday Inn, Bethesda, MD. The committee will discuss the draft guidance document entitled Guidance for the Clinical Evaluation of Weight-Control Drugs, issued 9/24/96. Contact Dornette Spell-LeSane, (301) 827-7001. To view this notice, click here.
